C Southan

Inactivation of dopamine beta-hydroxylase by p-cresol: evidence for a second, minor site of covalent modification at tyrosine 357.

C. Southan, L I Kruse, W E DeWolf, 1990, Biochimica et biophysica acta.

Bovine dopamine beta-hydroxylase, primary structure determined by cDNA cloning and amino acid sequencing.

R J Leatherbarrow, C. Southan, R. Leatherbarrow, 1990, Biochemistry.

A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29

C. Southan, M. Spedding, J. Armstrong, 2020, British journal of pharmacology.

Inactivation of dopamine beta-hydroxylase by beta-ethynyltyramine: kinetic characterization and covalent modification of an active site peptide.

C. Southan, L I Kruse, W E DeWolf, 1989, Biochemistry.

The impact of genomics on drug discovery.

C. Southan, D. Duckworth, D M Duckworth, 2000, Progress in medicinal chemistry.

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology

Adam J Pawson, Stephen P. H. Alexander, C. Southan, 2020, Immunology.

Inactivation of dopamine beta-hydroxylase by p-cresol: isolation and characterization of covalently modified active site peptides.

C. Southan, S. Carr, R. Dolle, 1988, Biochemistry.